Migraine frequency was reduced in two-thirds of adult patients treated at the Allegheny Hdche Ctr, Pittsburgh, with either divalproex or propanolol cf to 19% with placebo. [1]
Divalproex CF. Propanolol for Migraine Prophylaxis
DOI: https://doi.org/10.15844/pedneurbriefs-11-11-12 | Journal eISSN: 2166-6482
Language: English
Page range: 88 - 88
Published on: Nov 1, 1997
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 1997 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.